Prescribing Information can be found at the bottom of this page.
Marc
Has signs of metabolic syndrome
Marc, 63
Profile
- Diabetes, high blood pressure and obesity suggest metabolic syndrome1
- This is up to a third more prevalent in psoriasis patients than the general population1–3
Treatment goals
- Any treatment must take his metabolic syndrome into account
- Marc travels a lot for work and leisure, so wants a treatment he can take with him
“Psoriasis is a real drain on my energy.”
The benefits of ILUMETRI® for Marc:
PASI 75, 90 and 100 responses are well-maintained for up to 5 years of treatment with ILUMETRI®6
You might also be interested in
ILUMETRI® metabolic syndrome patient profile
Download additional information about the benefits of ILUMETRI® for patients with metabolic syndrome
References
- Singh S, et al. PLoS ONE 2017;12:e0181039.
- Lebwohl MG, et al. J Am Acad Dermatol 2021;84:398–407.
- Fernández-Armenteros JM, et al. J Eur Acad Dermatol Venereol 2019;33:128–135.
- ILUMETRI® Summary of Product Characteristics. Almirall.
- Reich K, et al. Lancet 2017;390:276–288.
- Thaçi D, et al. Br J Dermatol 2021. DOI: 10.1111/bjd.19866.
UK-ILU-2100104 November 2021